key: cord-0932574-0kvvcsfz
authors: Duan, Xiaohua; Tang, Xuming; Nair, Manoj S.; Zhang, Tuo; Qiu, Yunping; Zhang, Wei; Wang, Pengfei; Huang, Yaoxing; Xiang, Jenny; Wang, Hui; Schwartz, Robert E.; Ho, David D.; Evans, Todd; Chen, Shuibing
title: An Airway Organoid-Based Screen Identifies a Role for the HIF1α-Glycolysis Axis in SARS-CoV-2 Infection
date: 2021-10-15
journal: Cell Rep
DOI: 10.1016/j.celrep.2021.109920
sha: b98c7e05a57fbfce40f8a9cd380a74799cc291ad
doc_id: 932574
cord_uid: 0kvvcsfz

It is urgent to develop disease models to dissect mechanisms regulating SARS-CoV-2 infection. Here, we derive airway organoids from human pluripotent stem cells (hPSC-AOs). The hPSC-AOs, particularly ciliated-like cells, are permissive to SARS-CoV-2 infection. Using this platform, we perform a high content screen and identify GW6471, which blocks SARS-CoV-2 infection. GW6471 can also block infection of the B.1.351 SARS-CoV-2 variant. RNA-seq analysis suggests that GW6471 blocks SARS-CoV-2 infection at least in part by inhibiting HIF1α, which is further validated by chemical inhibitor and genetic perturbation targeting HIF1α. Metabolic profiling identifies decreased rates of glycolysis upon GW6471 treatment, consistent with transcriptome profiling. Finally, xanthohumol, 5-(Tetradecyloxy)-2-furoic acid, and ND-646, three compounds that suppress fatty acid biosynthesis, also block SARS-CoV-2 infection. Together, a high content screen coupled with transcriptome and metabolic profiling reveals a key role of the HIF1α-glycolysis axis in mediating SARS-CoV-2 infection of human airway epithelium.

analysis ( Figure 4B ) showed that profiles of control and GW6471-treated hPSC-AOs clustered 155 separately. Volcano plot ( Figure 4C ) and Ingenuity Pathway Analysis (IPA, Figure 4D , Table   156 S2) highlighted down-regulation of the HIF1α signaling pathway in treated cells. Likewise, 157 RNA-seq data from control and GW6471-treated hPSC-COs had profiles that clustered To test if decreased HIF1a signaling is functionally relevant to controlling infection, the 168 compound chetomin, a known small molecule suppressor for transcriptional activation of the 169 HIF1α pathway, was tested (Kung et al., 2004) . Both viral RNA replication ( Figure 4I ) and the 170 number of SARS-N + cells (Figure 4J and 4K) were significantly decreased following CoV-2 infection of hPSC-AOs, when treated with 1 μM chetomin. Similar to GW6471, chetomin 198 To determine whether HIF1α signaling controls glycolysis in the hPSC-AOs, we compared 199 transcript profiles of the control and chetomin-treated samples. PCA plots ( Figure 6A ) and 200 clustering analysis ( Figure 6B ) showed that profiles of control and chetomin-treated hPSC-AOs 201 clustered separately. Consistent with the results of GW6471-treated conditions (Figure 5E) , 202 genes encoding enzymes in the glycolysis pathway were suppressed in chetomin-treated 203 conditions ( Figure 6C ). RNA-seq was also applied to analyze the hPSC-AOs expressing 204 shHIF1α upon SARS-CoV-2 infection. Profiles from hPSC-AOs expressing scrambled RNA or 205 shHIF1α clustered separately ( Figure 6D and 6E) . RNA-seq analysis confirmed down-regulation 206 of the HIF1α pathway in hPSC-AOs expressing shHIF1α ( Figure 6F) . Interestingly, the 207 coronavirus replication pathway was also found to be down-regulated in hPSC-AOs expressing 208 shHIF1α upon SARS-CoV-2 infection ( Figure 6F ). Genes involved in the glycolysis pathway 209 are also down-regulated in hPSC-AOs expressing shHIF1α ( Figure 6G , Table S4 ). The hPSC-

AOs expressing shHIF1α show slightly decreased levels of ACE2 expression, but this difference 211 seems unlikely to be sufficient to explain the significant decrease of SARS-CoV-2 infection in 212 hPSC-AOs expressing shHIF1α ( Figure S4F ). Metabolic profiling also confirmed the decreased 213 levels of fatty acids, including palmitic acid, oleic acid, and palmitoleic acid, as well as 214 cholesterol, in hPSC-AOs expressing shHIF1α (Figure 6H-6I) . SARS-CoV-2 infected hPSC-two inhibitors of acetyl-CoA carboxylase 1, the key enzyme involved in fatty acid de novo 221 synthesis, were tested to further validate the role of fatty acid metabolism in SARS-CoV-2 222 infection. Both qRT-PCR ( Figure 6M ) and immunostaining ( Figure 6N and 6O) confirmed that 223 TOFA or ND-646 blocks SARS-CoV-2 infection in hPSC-AOs. Morbidity and mortality from COVID-19 is largely attributed to the acute viral pneumonitis that 227 evolves to acute respiratory distress syndrome. ACE2 is highly expressed in multiciliated cells of 228 the human airway (Ziegler et al., 2020) . We successfully developed an hPSC-AO platform, 229 containing AATB + FOXJ1 + ciliated-like cells that express ACE2. RNA-seq analysis of infected 230 organoids revealed upregulation of cytokine/chemokine signaling, which mimic the 231 inflammatory changes observed in primary human COVID-19 pulmonary infections (Blanco-232 Melo et al., 2020). We adapted the hPSC-AOs to a high content platform to screen for chemicals 233 that block SARS-CoV-2 infection. From a pilot screen, we identified GW6471 that blocks 234 SARS-CoV-2 infection not only in hPSC-AOs, but also in hPSC-COs, indicating that the anti-infection triggers mitochondrial ROS production, which induced HIF1α stabilization and 244 glycolysis. In our study, we found that GW6471 down-regulates the HIF1 pathway in both Cell lines. 476 The H1 and RUES2 hESCs were purchased from WiCell Research Institute Inc. The hESC H1 477 line was grown and maintained on 1% matrigel (Corning) coated six-well plates in homemade 478 mTesR1 medium at 37℃ under the 5% CO2 culture conditions. RUES2 hESCs were grown and 479 maintained on 1% Matrigel-coated six-well plates in StemFlex medium (Gibco) at 37C with 5% 480 CO2 culture condition. The medium was changed daily. When hESCs reached ~90% confluence, 481 the cells were passaged at 1:6-1:10 with ReLeSR (Stem Cell Technology). removed the next day. The cells were exposed to air for at least 14 days for further differentiation. Table S5 . Nuclei were counterstained by DAPI. Step qRT-PCR Kit (Invitrogen) with primers specific for the TRS-L and TRS-B sites for the N 580 gene as well as ACTB as an internal reference as described previously (Yang et al., 2020) .

Quantitative real-time PCR reactions were performed on an Applied Biosystems QuantStudio 6 Flex Real-Time PCR Instrument. Delta-delta-cycle threshold (ΔΔCT) was determined relative to 583 the ACTB and mock infected /treated samples. Error bars indicate the standard deviation of the 584 mean from three biological replicates. The sequences of primers/probes are provided in Table S6 .

High throughput chemical screening 587 hPSC-AOs were dissociated using TrypLE for 10 min in a 37℃ water bath and replated into 10% 588 Matrigel-coated 384-well plates at 10,000 cells/50 µl medium/well. After overnight plating, 589 compounds from a library containing signaling pathway regulators and FDA-approved drugs 590 were added at 10 µM. The detailed chemical information is listed as Table S1 . DMSO treatment 591 was used as a negative control. hPSC-AOs were then infected with SARS-CoV-2 (MOI=0.2).

After 48 hpi, hPSC-AOs were fixed for Immunofluorescence assays using the ImageXpress MICRO Single cell RNA-seq data analysis 634 We filtered cells with less than 500 or more than 6000 genes detected, cells with less than 1000 635 or more than 30000 UMIs detected, as well as cells with mitochondrial gene content greater than 636 15%, and used the remaining 7170 cells for downstream analysis.

We normalized the gene expression UMI counts using a deconvolution strategy implemented by 639 the R scran package (v.1.14.1). In particular, we pre-clustered cells using the quickCluster 640 function; we computed size factor per cell within each cluster and rescaled the size factors by 641 normalization between clusters using the computeSumFactors function; we normalized the UMI 642 counts per cell by the size factors and took a logarithm transform using the normalize function. To evaluate cell fates of hPSC-derived cells, we collected unique marker genes for fifteen 667 reference cell types in human adult lung based on a recent study (Travaglini et al., 2020) . We 668 compared the marker genes identified in our five clusters and those in the fifteen reference cell 669 types by calculating the fraction of overlapping marker genes. We performed z-score 670 transformation on raw fraction values across reference cell types and generated the cell-type 671 similarity heatmap plot using the R pheatmap package. We examined the expression of adult human ciliated and proximal ciliated cell marker genes in the hPSC-derived cells. In particular, 673 we assigned each cell a score by comparing the average expression of these marker genes to that 674 of a random set of background genes using the AddModuleScore function in the R Seurat 

.

We observed large fractions of viral reads in several SARS-CoV-2 infected hPSC-AOs, and as a 692 result, the human gene counts are significantly lower than those in the mock and treated samples.

To make a fair comparison, we down-sampled the raw gene counts in the mock and treated 694 samples, including Mock hPSC-AOs, GW6471 treated hPSC-AOs at 48 hpi (MOI=0.2) and 1 Figure S1 -S4, Tables S1-S6 and Movie S1-S2.

774 Table S1 . The information of chemicals used in high content screen. Related to Figure 3 . 

Inhibition of SARS-CoV-2 920

Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2

This work was supported by the Department of Surgery, Weill Cornell Medicine (T.E., S.C.),

Bill and Melinda Gates Foundation (S.C., T.E., R.E.S), (R01 DK124463, DP3 DK111907-01,